FIELD: medicine.
SUBSTANCE: patients' venous blood taken over the 1st phase of menstrual cycle with no heparin added as an anticoagulant is analysed for R-protein titres of red blood cell membranes. That is ensured by agglutination reaction with anti R-serum of a rabbit immunised with (0) Rh+ human red blood cells. If R-protein titre of red blood cell membranes is 1:1280, proliferation risk group is detected, while R-protein titre of red blood cell membranes being 1:2560 - 1:10240 enables genetic mutation risk group to be detected in the breast cancer jeopardised patients.
EFFECT: use of the method allows detecting early deviations of general regulatory adaptation reserves in the pathological conditions of breast and molecular genetic mutations capable to cause breast cancer.
8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING DISEASES OF MAMMARY GLAND IN WOMEN | 2002 |
|
RU2216732C1 |
| METHOD FOR DETECTING RISK GROUP FOR MAMMARY DISEASES IN WOMEN | 2002 |
|
RU2230491C2 |
| METHOD FOR DRUG PREVENTION OF BREAST CANCER | 2019 |
|
RU2708668C1 |
| METHOD OF PREDICTING A LOW RISK OF DEVELOPING BREAST CANCER IN WOMEN WITH HIGHLY PENETRATING MUTATIONS IN THE BRCA1 AND CHEK2 GENES | 2022 |
|
RU2798666C1 |
| METHOD FOR PREDICTION OF DEVELOPING MALIGNANT GROWTHS IN RADIATION EXPOSURE | 2012 |
|
RU2521393C2 |
| METHOD FOR IDENTIFYING RECESSIVE FACTORS OF GENETIC PREDISPOSITION TO BREAST CANCER | 2013 |
|
RU2535157C1 |
| METHOD FOR DETECTION OF RISK OF HEREDITAL DETERMINATION OF BREAST CANCER BASED ON ANAMNETIC DATA | 2016 |
|
RU2628865C1 |
| ANTIGEN FOR ANTICANCER ANTIBODIES | 2006 |
|
RU2356578C2 |
| SET OF SYNTHETIC OLIGONUCLEOTIDES FOR DETERMINATION OF NUCLEOTIDE SEQUENCE OF CODING PART OF BRCA1 GENE AND DETECTION OF MUTATIONS, ASSOCIATED WITH HEREDITARY FORMS OF BREAST CANCER | 2010 |
|
RU2440415C1 |
| MODIFIED INFLUENZA VIRUS FOR MONITORING AND INCREASING VACCINE EFFICACY | 2006 |
|
RU2420535C2 |
